This is a biotechnology company focused on the discovery, development and commercialization of therapeutics that may improve cancer treatment options for patients. This stock is trading up 7.2% at $20.63 in recent trading.Today's Volume: 1,825,000
Average Volume: 334,140
Volume % Change: 495% Shares of ABMD are ripping higher today after the company reported record revenue of $33.2 million and earnings of $2.9 million for the third quarter of fiscal 2012. From a technical standpoint, ABMD is starting to flirt with a major breakout since the stock has moved above some near-term overhead resistance at $21.50 just briefly intraday on monster volume. At last check, ABMD has cooled off to its current price of $20.60, so traders should now watch for a close above $21.50 and its daily high of $21.92 on high-volume. Look for volume on a move in the near future over those levels that are near or above 334,140 shares. If we get that action, soon, then I would look for long biased trades to play the breakout.